Qu, Rihao
Cheng, Xiuyuan
Sefik, Esen http://orcid.org/0000-0002-6807-3498
Stanley III, Jay S.
Landa, Boris
Strino, Francesco http://orcid.org/0000-0002-9310-4794
Platt, Sarah
Garritano, James
Odell, Ian D.
Coifman, Ronald
Flavell, Richard A. http://orcid.org/0000-0003-4461-0778
Myung, Peggy http://orcid.org/0000-0002-2970-4170
Kluger, Yuval http://orcid.org/0000-0002-3035-071X
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R01GM131642)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (UM1DA051410, U01DA053628)
U.S. Department of Health & Human Services | NIH | National Institute on Aging (U54AG076043, U54AG079759)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P50CA121974)
NSF | Directorate for Mathematical & Physical Sciences | Division of Mathematical Sciences (DMS-223784)
U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR076420)
Article History
Received: 19 December 2022
Accepted: 26 February 2024
First Online: 5 April 2024
Competing interests
: R.A.F. is an advisor to GlaxoSmithKline, Zai Lab and Ventus Therapeutics. F.S. is employed as a director by PCMGF Limited. I.D.O. is the founder and president of Plythera and receives research funding from Ventus Therapeutics and SenTry.